HKEX:0512 Short term 20 days. Potential profit 11%HKEX:512
Buy in at 5.21
Cut loss at 4.98
Target at 5.79
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.065 EUR
306.82 M EUR
1.45 B EUR
1.05 B
About Grand Pharmaceutical Group Limited
Sector
Industry
CEO
Chao Zhou
Website
Headquarters
Hong Kong
Founded
1995
ISIN
BMG210A71016
FIGI
BBG002JCLZJ7
Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. Its products offer ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. It operates through the following geographical segments: The People's Republic of China (PRC), America, Europe, Asia other than the PRC, and Others. The company was founded on October 18, 1995 and is headquartered in Hong Kong.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Grand Pharmaceutical Group Limited stocks are traded under the ticker MX6A.
We've gathered analysts' opinions on Grand Pharmaceutical Group Limited future price: according to them, MX6A price has a max estimate of 1.43 EUR and a min estimate of 1.28 EUR. Watch MX6A chart and read a more detailed Grand Pharmaceutical Group Limited stock forecast: see what analysts think of Grand Pharmaceutical Group Limited and suggest that you do with its stocks.
MX6A reached its all-time high on Jun 12, 2025 with the price of 1.070 EUR, and its all-time low was 0.380 EUR and was reached on Feb 9, 2024. View more price dynamics on MX6A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Grand Pharmaceutical Group Limited financials in yearly and quarterly reports right on TradingView.
Grand Pharmaceutical Group Limited is going to release the next earnings report on Mar 18, 2026. Keep track of upcoming events with our Earnings Calendar.
MX6A net income for the last half-year is 126.38 M EUR, while the previous report showed 113.17 M EUR of net income which accounts for 11.67% change. Track more Grand Pharmaceutical Group Limited financial stats to get the full picture.
Yes, MX6A dividends are paid annually. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 3.11%. Tracking Grand Pharmaceutical Group Limited dividends might help you take more informed decisions.
Grand Pharmaceutical Group Limited dividend yield was 5.42% in 2024, and payout ratio reached 36.88%. The year before the numbers were 6.36% and 48.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 29, 2025, the company has 11.99 K employees. See our rating of the largest employees — is Grand Pharmaceutical Group Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Grand Pharmaceutical Group Limited EBITDA is 245.95 M EUR, and current EBITDA margin is 21.87%. See more stats in Grand Pharmaceutical Group Limited financial statements.
Like other stocks, MX6A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Grand Pharmaceutical Group Limited stock right from TradingView charts — choose your broker and connect to your account.